P H A R M A C E U T I C A L

Benchmark Report

s a m b a s a f e t y . c o m 2

The continuously evolving pharmaceutical industry is highly regulated with no signs of slowing down and faces a number of everyday industry-specific safety concerns.

How often are you or your organization thinking about employee driver safety, if at all? Your pharmaceutical counterparts are starting to consider how employee driver safety impacts your brand, business and bottom line.

DRIVER AND VEHICLE RISKS

How are you handling employee-driver safety and risk today?

In addition to salesperson travel, the most significant area of vehicle and driver risk within the pharmaceutical industry is related to supply chain security and integrity, with temperature and quality of shipments top of mind. Respondents also indicated that theft and diversion were of concern. Do you feel behavior on the clock in a vehicle can be indicative of behavior off the clock outside of a vehicle?

The importance of having the right drivers behind the wheel proves absolutely vital to the pharmaceutical industry. Continuous driver monitoring can help, whether informing businesses of driver criminal history or helping you better understand of driver behavior trends.

Very High =

mean score of 8 and higher

High =

mean score 7-8

Moderate =

mean score 4-7

Low =

mean score below 4

Mean rating on 10point scale where

1 = not compelling

10 = very compelling

COMPLIANCEVery High

Benefits of Mitigating Driver-Related RiskBY CATEGORY

BRANDHigh

FINANCIALVery High

PERSONNEL-RELATEDHigh

PROACTIVE/PREVENTATIVEVery High

Importance of Driver Risks

Equipment operation at worksite /factory / stores

Delivery services / truck / transportation

Salesperson travel / education reps /international travel

Office / campus shuttles

Driving at worksite / office / campus

Executive business travel

Supply chain security / shipment integrity /quality control / theft

Lawn / landscape / snow removal /maintenance / security operations

Transporting clients / individuals /entertainment / events

Employee conferences / training related travel

Employee travel to/from worksite / office

Reimbursable vehicle travel

Employee work-related errands/supervisory travel

9.3

8.0

7.7

7.5

7.3

7.3

7.0

6.7

6.3

6.3

6.0

5.7

5.0

Mean rating on 10 point scale where 1 = not important, 10 = important.

Benefits of MitigatingDriver-Related Risk

Proactive increase of driver training andsafety initiative across the organization

Increase in regulatory compliance

Reduction in workplace accidents /campus accidents

Reduction in total cost of risk

Increase proactivity ofcrisis management planning

Increase in overall profitability

Promoting a culture of health / safety

Reduction in lawsuits / litigation /settlements / legal fees

Decrease in reputational risk /brand-related risk

Reduction in insurance claims /auto insurance claims

Increase employee retention

Reduction in insurance rates

Reduction in workers compensation claims

Brand benefits – advocating /supporting public safety

9.5

9.3

8.7

8.5

8.3

8.0

8.0

8.0

7.7

7.0

7.0

6.3

6.3

7.0

Mean rating on 10 point scale where 1 = not compelling, 10 = very compelling.

s a m b a s a f e t y . c o m 3

IMPORTANCE AND BENEFITS OF DRIVER RISK RANKED BY PRIORITY

THE CHALLENGE

High or low risk?

Those within the pharmaceutical industry rated employee auto exposure and fleet activity as high risk components in sales and the supply chain. One of the highest areas of risk for those in the industry is salesperson travel. Salesperson travel presents more traditional risk and takes into account considerable financial impact brought on by vehicle damage, claims and injuries. Large pharmaceutical companies also encounter high financial and

personal injury risk related to salesperson travel.

Old versus new

There is no denying that driver and vehicle risk mitigation programs vary. Whether an outsourced post-hire background check, fleet management pro-gram or in-house point-based systems, suffice to say that six-month reviews of motor vehicle records or mobile training platforms just aren’t cutting it.

One respondent indicated that when outsourcing background checks and pulling motor vehicle records (MVRs), the cadence of pulling on an annual basis was not ideal considering driver information was not routinely reported back to the risk department.

After implementing an automated continuous driver monitoring solution, another respondent detailed how their company went from no driver safety program to robust risk-scoring. Additionally, they were able to receive con-tinuous updates of detrimental MVR changes and tutorials, substantially reducing incident costs.

Does your company have a driver safety program in place today? If so, what does that policy look like and how do you enforce that policy throughout the year?

s a m b a s a f e t y . c o m 4

s a m b a s a f e t y . c o m 5

THE SOLUTION

MVR Monitoring

The surveyed pharmaceutical risk executives believed that near real-time insight into motor vehicle records was a compelling solution.

Tools associated with continuous driver monitoring were seen as beneficial when managing equipment operators in warehouses, salespeople and those transporting products. The near real-time reporting was a substantial benefit and the insight associated with future decision-making predictive analytics was also mentioned.

Many in the pharmaceutical industry hire transportation companies for ship-ping needs and therefore do not have direct responsibility for hiring drivers but indicated that they expect shippers to use continuous driver monitoring.

Safety programs and training

How does continuous driver monitoring impact safety in front of and behind the wheel as well as the challenges cited above?

Continuous monitoring automates a previously manual process, alerting organizations in near real-time to violations incurred. In turn, this insight informs companies of employees who put the product, themselves and the organization’s brand and bottom line at risk. With continuous driver moni-toring, those in the pharmaceutical industry reported improved operational efficiencies and visibility into risky driving behaviors.

Some highly compelling benefits when mitigating driver risk through con-tinuous driver monitoring include proactively upping driver training, better enforcing a safety policy, increasing regulatory compliance, reducing campus and workplace incidents as well as reducing total cost of risk.

The least compelling priority when mitigating driver-related risk? A reduction in workers compensation payouts and brand benefits associated with positive driver management.

CONCLUSION

The pharmaceutical industry takes risk prevention seri-ously, but as new solutions surrounding transporting life-saving products come about, new challenges emerge as well. Driver safety is of paramount importance within the industry and manual MVR pulls are a way of the past.

Continuous driver monitoring is an effective, automated solution that can improve pharmaceutical company safety for employees, communities and the customers they serve. What steps are you taking to lower your risk?

Violation %

2018

2017

0% 20% 40% 60% 80% 100%

14.12%

8.42%

Action %

2018

2017

0% 20% 40% 60% 80% 100%

1.47%

0.97%

Clean %

2018

2017

0% 20% 40% 60% 80% 100%

78.05%

77.08%

Major %

2018

2017

0% 20% 40% 60% 80% 100%

2.43%

1.51%

Findings

Number of events of type 'VIOLATION' / Monitored Person Number of events of type 'ACTION' / Monitored Person

Number of MVRs with no events / Number of orders Number of events of type 'VIOLATION' that has the Risk Category of 'MAJOR' / Monitored Person

VISUALIZATION OF IMPROVEMENT IN OUTCOMES WITH CONTINUOUS DRIVER MONITORING IN PLACE

s a m b a s a f e t y . c o m 6